Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
SetPoint Medical, founded in 2007 and headquartered in Valencia, California, is a clinical-stage healthcare company specializing in innovative treatments for chronic autoimmune diseases. The company's primary focus is on developing a platform that utilizes targeted electrical stimulation to activate the body's natural anti-inflammatory pathways, aiming to restore immunologic balance and regulate inflammation. SetPoint Medical's technology primarily addresses conditions such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Since its inception, SetPoint Medical has raised a total of $274.16 million in funding, demonstrating significant investor interest in its innovative approach to treating autoimmune disorders. The company's unique technology platform and focus on addressing unmet medical needs in the autoimmune disease market have positioned it as a notable player in the medical device industry.
As of now, there is no concrete information available regarding SetPoint Medical's plans for an initial public offering (IPO). The company has not made any official announcements or filed any public documents indicating its intention to go public. Without specific news or reports about SetPoint Medical's IPO prospects, it is not possible to provide accurate information about potential listing plans or timelines.
Factors that could influence SetPoint Medical's decision to pursue an IPO in the future may include the progress of its clinical trials, regulatory approvals, market conditions, and the company's overall financial health. However, it's important to note that these are general considerations, and the company's actual plans may vary based on its specific circumstances and strategic objectives.
Investors interested in SetPoint Medical should continue to monitor official company announcements and industry news for any updates regarding potential IPO plans or other significant developments in the company's growth trajectory.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While SetPoint Medical's IPO prospects remain uncertain, investors interested in innovative medical technology companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the biotech and medical device sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging healthcare innovators before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
